124 related articles for article (PubMed ID: 8232230)
1. Antisera against peptides derived from a purified mu-opioid binding protein recognize the protein as well as mu-opioid receptors in brain regions and a cell line.
Gioannini TL; Yao YH; Hiller JM; Taylor LP; Simon EJ
Mol Pharmacol; 1993 Oct; 44(4):796-801. PubMed ID: 8232230
[TBL] [Abstract][Full Text] [Related]
2. Development of polyclonal anti-D2 dopamine receptor antibodies using sequence-specific peptides.
Boundy VA; Luedtke RR; Artymyshyn RP; Filtz TM; Molinoff PB
Mol Pharmacol; 1993 May; 43(5):666-76. PubMed ID: 8502224
[TBL] [Abstract][Full Text] [Related]
3. Antibodies to the cloned mu-opioid receptor detect various molecular weight forms in areas of mouse brain.
Garzon J; Juarros JL; Castro MA; Sanchez-Blazquez P
Mol Pharmacol; 1995 Apr; 47(4):738-44. PubMed ID: 7723734
[TBL] [Abstract][Full Text] [Related]
4. Development of an antiserum against m3 muscarinic receptors: distribution of m3 receptors in rat tissues and clonal cell lines.
Wall SJ; Yasuda RP; Li M; Wolfe BB
Mol Pharmacol; 1991 Nov; 40(5):783-9. PubMed ID: 1944243
[TBL] [Abstract][Full Text] [Related]
5. Beta-[3H]funaltrexamine-labeled mu-opioid receptors: species variations in molecular mass and glycosylation by complex-type, N-linked oligosaccharides.
Liu-Chen LY; Chen C; Phillips CA
Mol Pharmacol; 1993 Oct; 44(4):749-56. PubMed ID: 8232225
[TBL] [Abstract][Full Text] [Related]
6. Direct measurements of in situ interactions of rat brain opioid receptors with the guanine nucleotide-binding protein Go.
Georgoussi Z; Carr C; Milligan G
Mol Pharmacol; 1993 Jul; 44(1):62-9. PubMed ID: 8393523
[TBL] [Abstract][Full Text] [Related]
7. Identification of the critical domains of the delta-opioid receptor involved in G protein coupling using site-specific synthetic peptides.
Merkouris M; Dragatsis I; Megaritis G; Konidakis G; Zioudrou C; Milligan G; Georgoussi Z
Mol Pharmacol; 1996 Oct; 50(4):985-93. PubMed ID: 8863845
[TBL] [Abstract][Full Text] [Related]
8. Anti-human kappa opioid receptor antibodies: characterization of site-directed neutralizing antibodies specific for a peptide kappa R(33-52) derived from the predicted amino terminal region of the human kappa receptor.
Buchner RR; Vogen SM; Fischer W; Thoman ML; Sanderson SD; Morgan EL
J Immunol; 1997 Feb; 158(4):1670-80. PubMed ID: 9029103
[TBL] [Abstract][Full Text] [Related]
9. Comparison of [Dmt1]DALDA and DAMGO in binding and G protein activation at mu, delta, and kappa opioid receptors.
Zhao GM; Qian X; Schiller PW; Szeto HH
J Pharmacol Exp Ther; 2003 Dec; 307(3):947-54. PubMed ID: 14534366
[TBL] [Abstract][Full Text] [Related]
10. Molecular cloning and functional expression of a mu-opioid receptor from rat brain.
Chen Y; Mestek A; Liu J; Hurley JA; Yu L
Mol Pharmacol; 1993 Jul; 44(1):8-12. PubMed ID: 8393525
[TBL] [Abstract][Full Text] [Related]
11. Selective interactions between G protein subunits and RGS4 with the C-terminal domains of the mu- and delta-opioid receptors regulate opioid receptor signaling.
Georgoussi Z; Leontiadis L; Mazarakou G; Merkouris M; Hyde K; Hamm H
Cell Signal; 2006 Jun; 18(6):771-82. PubMed ID: 16120478
[TBL] [Abstract][Full Text] [Related]
12. Immunohistochemical localization of mu-opioid receptors in rat brain using antibodies generated against a peptide sequence present in a purified mu-opioid binding protein.
Hiller JM; Zhang Y; Bing G; Gioannini TL; Stone EA; Simon EJ
Neuroscience; 1994 Oct; 62(3):829-41. PubMed ID: 7870310
[TBL] [Abstract][Full Text] [Related]
13. Neuropeptide FF (NPFF) analogs functionally antagonize opioid activities in NPFF2 receptor-transfected SH-SY5Y neuroblastoma cells.
Mollereau C; Mazarguil H; Zajac JM; Roumy M
Mol Pharmacol; 2005 Mar; 67(3):965-75. PubMed ID: 15608144
[TBL] [Abstract][Full Text] [Related]
14. Delta and mu opioid receptors from the brain of a urodele amphibian, the rough-skinned newt Taricha granulosa: cloning, heterologous expression, and pharmacological characterization.
Bradford CS; Walthers EA; Stanley DJ; Baugh MM; Moore FL
Gen Comp Endocrinol; 2006 May; 146(3):275-90. PubMed ID: 16375901
[TBL] [Abstract][Full Text] [Related]
15. Opioid peptide receptor studies. 17. Attenuation of chronic morphine effects after antisense oligodeoxynucleotide knock-down of RGS9 protein in cells expressing the cloned Mu opioid receptor.
Xu H; Wang X; Wang J; Rothman RB
Synapse; 2004 Jun; 52(3):209-17. PubMed ID: 15065220
[TBL] [Abstract][Full Text] [Related]
16. Cloning and expression of ligand-gated ion-channel receptor L2 in central nervous system.
Houtani T; Munemoto Y; Kase M; Sakuma S; Tsutsumi T; Sugimoto T
Biochem Biophys Res Commun; 2005 Sep; 335(2):277-85. PubMed ID: 16083862
[TBL] [Abstract][Full Text] [Related]
17. Interaction between the mu opioid receptor and filamin A is involved in receptor regulation and trafficking.
Onoprishvili I; Andria ML; Kramer HK; Ancevska-Taneva N; Hiller JM; Simon EJ
Mol Pharmacol; 2003 Nov; 64(5):1092-100. PubMed ID: 14573758
[TBL] [Abstract][Full Text] [Related]
18. Affinity purification and comparative analysis of two distinct human uracil-DNA glycosylases.
Caradonna S; Ladner R; Hansbury M; Kosciuk M; Lynch F; Muller S
Exp Cell Res; 1996 Feb; 222(2):345-59. PubMed ID: 8598223
[TBL] [Abstract][Full Text] [Related]
19. Effect of chronic ethanol and withdrawal on the mu-opioid receptor- and 5-Hydroxytryptamine(1A) receptor-stimulated binding of [(35)S]Guanosine-5'-O-(3-thio)triphosphate in the fawn-hooded rat brain: A quantitative autoradiography study.
Chen F; Lawrence AJ
J Pharmacol Exp Ther; 2000 Apr; 293(1):159-65. PubMed ID: 10734165
[TBL] [Abstract][Full Text] [Related]
20. Mu opioid receptor coupling to Gi/o proteins increases during postnatal development in rat brain.
Talbot JN; Happe HK; Murrin LC
J Pharmacol Exp Ther; 2005 Aug; 314(2):596-602. PubMed ID: 15860573
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
